Lallemand Pharma

News details

Jan
30,
2020

Lallemand Pharma sustained EBI’s innovation and entrepreneurship

Jan 30, 2020

On January 17th2020, Lallemand Pharma sustained the 15th anniversary of “Grand Oral” of Marketing and Entrepreneurship organized by EBI, a French engineering school specialized in Bio-Industries based in Cergy-Pontoise.

During the event, which took place in the prestigious MEDEF* Amphitheatre in Paris, twelve groups of EBI students presented their projects in front of a jury of professionals in Marketing, Finance and Industry.

The vocation of EBI being to educate and train engineers dedicated to “Life Sciences”, the variety of the projects presented covered a multitude of innovative topics aimed to improve the quality of life of each individuals such as: Health, Cosmetics, Environment, Food industry, Personal assistance, Road safety…

After deliberation and votes following each session all the day, the jury selected five projects for their promising future and to encourage their presentation, innovation and seriousness, Lallemand Pharma awarded the best projects with financial grant which was shared between the top 2 groups of winners:

  • Little’biote in the topic of Health was ranked first place
  • Daily’gumes in the topic of Food Industry was ranked second place

The three last projects awarded were in cosmetics, road safety and food industry.

Maxence de Villemeur, Marketing and Sales Director, and ancient student of EBI, commented: “it is natural way that Lallemand Pharma brings its collaboration to EBI projects thanks to their mutual focus and interests in innovative products in the biological field, and even more Life’s applications“.

Lallemand Pharma, Inspiring Healthy future….to the new generation

Discover the movie of the “Grand Oral 2020”: https://youtu.be/DLNMkuqlOA0

About Lallemand Pharma
Lallemand Pharma AG, based in Massagno, Switzerland, is in charge of the global business and possesses the intellectual property rights of an immunostimulant drug indicated in the prevention of respiratory infections known as PMBL® sublingual tablets and develops various medical devices applications. The company is dedicated to clinical studies, registrations, marketing and sales of PMBL®.

www.lallemandpharma.com

About EBI 

EBI (Ecole de Biologie Industrielle), is a french school of engineers in Bio-Industries. A recent survey in the journal “Les Echos”, the school was ranked number 2 among all national engineering schools in France for the entrepreneurship. EBI educates in this way the French leaders of tomorrow in the Life Sciences.

https://ebi-edu.com/en/

 

* Mouvement des entreprises de France